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SUMMARY 39 
 A serine protease-like enzyme found in detergent extracts of S. mansoni adult 40 
worms perfused from infected mice has been purified from mouse blood and further 41 
characterized. The enzyme is approximately 85 kDa and hydrolyses N-acetyl-DL-42 
phenylalanine β-naphthyl–ester, a chromogenic substrate for chymotrypsin-like 43 
enzymes. The enzyme from S. mansoni worms appears to be antigenically and 44 
enzymatically similar to a molecule that is present in normal mouse blood and so is 45 
seemingly host-derived. The enzyme was partially purified by depleting normal 46 
mouse serum of albumin using sodium chloride and cold ethanol, followed by 47 
repeated rounds of purification by one dimensional sodium dodecyl sulphate 48 
polyacrylamide gel electrophoresis (1-D SDS-PAGE). The purified material was 49 
subjected to tandem mass spectrometry and its derived peptides found to belong to 50 
mouse carboxylesterase 1C (CES1C).  Its ability to hydrolyse α- or β-naphthyl 51 
acetates, which are general esterase substrates, has been confirmed. A similar 52 
carboxylesterase was purified and characterized from rat blood. Additional evidence 53 
to support identification of the enzyme as a carboxylesterase has been provided. 54 
Possible roles of the enzyme in the mouse host-parasite relationship could be to 55 
ease the passage of worms through the host’s blood vessels and/or in immune 56 
evasion.  57 
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KEY FINDINGS 62 
 A host-derived enzyme found in detergent extracts of adult S. mansoni worms 63 
from infected mice has been purified. 64 
 Physical and biochemical characteristics of the enzyme enabled its 65 
characterization as a carboxylesterase. 66 
 The purified enzyme hydrolysed two esterase substrates: β-naphthyl and α-67 
naphthyl acetates. 68 
 The purified enzyme was inhibited by a serine protease inhibitor and a 69 
carboxylesterase inhibitor. 70 
 The host-derived carboxylesterase could play a role in host physiology and/or 71 
immune evasion.   72 
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INTRODUCTION 83 
Schistosomes are long-lived parasitic flat worms inhabiting host vasculature. 84 
Five species out of twenty are able to infect man, establishing a chronic infection 85 
(Standley et al., 2012). One immune evasive strategy employed by the parasite and 86 
presumed to prolong its survival is the acquisition of host molecules. Several host 87 
molecules have been reported on the surface of Schistosoma mansoni adult worms, 88 
including blood group antigens (Smithers et al., 1969), major histocompatibility 89 
complex antigens (Simpson et al., 1986), immunoglobulins (Kemp et al., 1976), host 90 
lipids (Furlong et al., 1992), lipoproteins (Dinguirard and Yoshino, 2006), alpha-2-91 
macroglobulin (Damian et al., 1973), contrapsin (Modha et al., 1988) and 92 
components of the complement system (Skelly, 2004). 93 
A relationship between a host-derived chymotrypsin-like serine protease 94 
present in detergent extracts of S. mansoni worms that had been perfused from 95 
infected mice and also in mouse blood was previously reported by Darani and 96 
Doenhoff (2008). The enzyme was found in a detergent (deoxycholic acid - DOC) 97 
extract of worms with relatively little being found in non-detergent extracts and it was 98 
seemingly identical antigenically and enzymatically to the molecule in mouse serum. 99 
The antigen in the worm extract and normal mouse serum were both 100 
immunoprecipitated in immunoelectrophoresis by a rabbit antiserum raised against 101 
whole mouse serum (anti-NMS) (Darani and Doenhoff, 2008). The enzyme activity 102 
was visualized using N-acetyl-DL phenylalanine β-naphthyl ester (NAPBNE), a 103 
chromogenic substrate of chymotrypsin-like enzymes. The molecule in both the DOC 104 
worm extracts and NMS is of interest because it is unusual for an enzymatically-105 
active form of a protease to be present in blood - most are there as inactive pro-106 
enzymes or in zymogen form. Furthermore, while the active enzyme has been found 107 
in mouse and rat blood, it was not found in the blood of several other mammalian 108 
species including sheep, cattle and humans (Darani and Doenhoff, 2008).  109 
This study reports the purification and characterization of the mouse plasma-110 
derived chymotrypsin-like enzyme, which we believe to be identical to that found on 111 
the surface of S. mansoni worms recovered from infected mice. Mass spectrometry 112 
helped determine the amino acid sequence of the enzyme which in turn enabled it to 113 
be identified and further characterized. Information so derived gave insights into its 114 
possible role in the host parasite relationship. 115 
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MATERIALS AND METHODS 128 
 All chemicals and buffers were of analytical grade and bought from Sigma-129 
Aldrich Company limited, UK, except when otherwise stated. These included 130 
absolute ethanol, sodium acetate, the salt constituents of phosphate buffered saline 131 
(PBS), Tris, triton-X100, N, N, N-acetyl-DL-phenylalanine β-naphthyl ester 132 
(NAPBNE), fast blue B salt (FBB), β-naphthyl acetate, α-naphthyl acetate, fast red 133 
TR, dimethyl sulfoxide (DMSO) and glycine. 134 
 135 
Parasite extract and antigens 136 
 A  Puerto Rican isolate of S. mansoni was routinely used for infection of mice 137 
for experimental work and production of adult worm antigens. The isolate has been 138 
maintained by continuous passage in random-bred mice and Biomphalaria glabrata 139 
snails, the intermediate host for the generation of cercaria. Adult schistosomes were 140 
recovered by portal perfusion of infected mice 42 days after infection, as described 141 
originally by Smithers and Terry (1965) and modified by Doenhoff et al. (1978).  142 
 Detergent extracts of S. mansoni worms (WM) were prepared by re-143 
suspending freshly perfused, gravity-sedimented worms which had had all visible 144 
traces of erythrocytes removed from the suspending fluid, in twice their volume of 145 
2% deoxycholic acid (detergent) solution in isotonic saline as previously described 146 
by Doenhoff et al. (1988). The suspension was gently agitated for 4 hours at room 147 
temperature and then centrifuged. The supernatant was removed and stored at -148 
800C until used for rabbit immunization or in immunoprecipitation studies. 149 
 150 
 151 
Normal mouse serum (NMS) and normal rat serum (NRS) 152 
 Normal mouse serum and normal rat serum were prepared by exsanguinating 153 
healthy uninfected animals of the respective species. Collected blood was put into 154 
universal tubes and stored in a fridge at 40C for 4 hours to clot. The blood clots were 155 
ringed with a pipette to aid separation of the clot from serum and the serum 156 
removed, centrifuged at 2,500 x g for 6 minutes at 40C and the clear supernatant 157 
removed and stored at -800C until use. 158 
 159 
Rabbit anti-normal mouse serum (Anti-NMS) 160 
 A polyspecific rabbit anti-normal mouse serum antiserum was prepared as 161 
described by Darani and Doenhoff (2008) by repeated weekly injections of 1 ml 162 
emulsion containing equal volumes of normal mouse serum and Freund’s adjuvant. 163 
The response was assessed qualitatively in terms of the intensity of immuno-164 
precipitation lines yielded by the serum and the homologous antigen extract. The 165 
rabbit was serially bled weekly from alternate ears until enough serum was collected. 166 
The serum pool was divided into 5 ml aliquots and stored at -200C. 167 
 168 
Rabbit anti- complete Freund’s adjuvant (Anti-CFA) 169 
    Rabbit anti-CFA was prepared as described for anti-NMS except that rabbits were 170 
injected only with repeated weekly doses of 1 ml emulsion of CFA. 171 
 172 
Rabbit anti-mouse serum albumin (anti-MSA)  173 
 A rabbit anti-mouse serum albumin antiserum was raised by immunization 174 
with replicate immunoprecipitin arcs produced by immunoelectrophoresis of mouse 175 
serum albumin and anti-NMS as described by Goudie et al. (1966), adapted as in 176 
Dunne et al. (1986). Immunoprecipitin arcs were excised, homogenized and injected 177 
into rabbits at weekly intervals. Antibody responses of Immunized rabbits were 178 
monitored and finally bled as described for the rabbit anti-NMS.  179 
        180 
Rabbit anti-worm protease antiserum 181 
        A rabbit antiserum specific for the chymotrypsin-like enzyme in NMS was 182 
prepared as described by Darani and Doenhoff (2008).   183 
 184 
Reduction of albumin in NMS and NRS 185 
 Serum albumin was depleted from both NMS and NRS as described by 186 
Colantonio et al. (2005). NaCl was added to a known volume of each serum in a 187 
micro-tube to give a final concentration of 0.1 M and the mixture incubated with 188 
gentle rotation for 60 minutes at 40C. Cold ethanol was added to the mixture to yield 189 
a final concentration of 42% v/v and incubated for a further 60 minutes at 40C. The 190 
mixture was centrifuged at 16000 x g for 45 minutes at 40C and the resultant 191 
supernatant transferred into a sterile micro tube ‘B’ for further processing while 192 
retaining the pelleted precipitate in the first tube ‘A’. The pH of the supernatant was 193 
lowered to 5.7 by adjusting with cold 0.8 M sodium acetate, pH 4.0 and incubated at 194 
40C for 60 minutes. The mixture was centrifuged as above and supernatant 195 
containing mainly albumin transferred into sterile micro-tube ‘C’ while retaining the 196 
pelleted precipitate. The first and second precipitates were separately reconstituted 197 
with 0.1 M PBS, pH 7.4 (weight/volume) and stored at -200C. The protein 198 
concentration in NMS was 23.70 mg/ml while concentrations in solutions of the two 199 
precipitates A and B and the supernatant were 5.50, 5.90 and 10.90 mg/ml 200 
respectively. 201 
 202 
Immunochemistry for the detection and purification of the chymotrypsin-like enzyme 203 
 Single radial immunodiffusion (RID) (Mancini et al., 1965) was carried out as 204 
described by Darani et al. (1997), on microscopic glass slides using 1% molten 205 
agarose in 0.06 M barbitone buffer, pH 8.6. The immuno-precipitate was washed in 206 
several changes of 0.9% saline to remove non-immunoprecipitated material.  207 
 Purification of the chymotrypsin-like enzyme in mouse and rat sera was 208 
achieved in one-dimensional sodium dodecyl 12% acrylamide gel electrophoresis 209 
(Laemmli, 1970) as modified by Studier (1973). 18 ug of each serum (mouse or rat) 210 
were loaded into separate gels with broad wells (6.2 cm long) in replicates and 211 
electrophoresed. Bands with enzymatic activity were excised from replicate thin 212 
strips of the polyacrylamide gel, put into a 1.5 ml Eppendorf container and covered 213 
with a minimum volume of elution buffer (0.06 M Tris-HCl, 10% SDS, pH 7.0) (Beyer 214 
et al., 2008). The tube was incubated at 370C for 24 hours, centrifuged at 14,000 x g 215 
for 30 minutes at the same temperature and the resultant eluate was removed. 216 
Further purification of the enzyme was achieved by re-electrophoresing the eluate in 217 
a fresh SDS-PAGE gel. The whole sequence of (i) SDS-PAGE, (ii) elution of enzyme 218 
activity from gel strips, (iii) re-electrophoresing in PAGE was repeated three times in 219 
an effort to obtain a sufficiently pure sample of the enzyme suitable for analysis by 220 
mass spectrometry (MS). PAGE gels carrying proteins for analysis in MS were 221 
stained using SimplyBlue SafeStain (Invitrogen, Carlsbad, CA). 222 
Ouchterlony double immunodiffusion was adapted from Bailey (1996). Glass 223 
microscope slides were sterilized by spraying 70% alcohol on both sides and wiping 224 
with a sterile tissue. They were placed on a levelled table and 4 ml, 1.2% molten 225 
agarose dissolved in sodium barbitone solution (pH 8.6) was spread on the glass 226 
slide and allowed to set. Circular wells were cut in the gel and these were loaded 227 
with desired antigen solutions and antisera. The slides were incubated in a humid 228 
chamber for 16 hours to allow immunoprecipitation and then washed in 0.9% saline 229 
solution for 48 hours. Enzymatic activity was assayed using both chymotrypsin-like 230 
(NAPBNE + FBB) and CES (α-naphthyl acetate + fast red TR) substrates as 231 
described below. 232 
 233 
Immunofluorescence on the surface of adult worms 234 
Immunofluorescence on adult worms was done as described in Doenhoff et al 235 
1988. Briefly, adult worms perfused from infected mice were washed several times in 236 
perfusion fluid and fixed in 4% paraformaldehyde in isotonic PBS solution pH 7.4, 237 
overnight. Thereafter, the worms were washed thrice in isotonic PBS solution. The 238 
fixed worms were incubated in blocking buffer (1% BSA in PBST (PBS + 0.2% 239 
Tween 20) for an hour at room temperature and washed in PBST solution.  240 
Primary incubation of the blocked adult worms was done in a 1:40 dilution of a 241 
rabbit antiserum raised against the host-derived protease/CES in 1 ml PBST and 242 
incubated overnight at 4ºC. Worms were washed three times in PBST as above and 243 
incubated in 1 ml 1:80 FITC-labelled secondary goat anti-rabbit IgG (Abcam, 244 
Cambridge, UK) in PBST for 30 minutes at room temperature in the dark. The 245 
labelled worms were washed 3 times in PBST and examined with the aid of a GX 246 
fluorescence microscope (GMXL3201LED) using the 10x objective lens under blue 247 
light attached to a GXCAMFLUOMAX camera (GT Vision Ltd www.gxoptical.com).  248 
 249 
Mass spectrometric analysis of purified enzymes  250 
 Analyses of purified gel bands were carried out using tandem mass 251 
spectrometry (Papayannopoulos, 1995, Steen and Mann, 2004). Purified protein was 252 
digested by trypsin and fragmented peptides ionised and accelerated in a mass 253 
analyser where ion fragments were separated on the basis of mass-to-charge to 254 
produce spectra. Data from the resulting mass spectra were searched using the 255 
MASCOT software for peptide matching and protein identification. Amino acid 256 
sequence searches used the protein basic local alignment search tool (pBLAST) at 257 
the National Centre for Biotechnology Information (NCBI) against the non-redundant 258 
protein sequences database (nr) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to identify 259 
homologous proteins, while the protein sequence alignment was achieved using 260 
ClustalW software (http://www.ebi.ac.uk/Tools/msa/clustalw/).  261 
 262 
Detection of chymotrypsin-like enzyme activity 263 
 Zymography for the detection of chymotrypsin-like enzyme activity in agarose 264 
films in RID and SDS-PAGE gels was performed as described by Pearse (1968), 265 
adapted as in Darani and Doenhoff (2008), using 5 mg NAPBNE as the chromogenic 266 
substrate and 5 mg FBB as the coupling agent. The substrate mixture was dissolved 267 
in 2 ml DMSO and diluted to 40 ml by adding 10 ml, 0.1 M PBS solution, pH 7.4 and 268 
30 ml deionized water. Prior to zymography in SDS-PAGE, the gel was incubated for 269 
an hour in 2.5% triton X-100 solution. 270 
 271 
 Detection of esterase activity 272 
 Esterase activity on purified mouse and rat enzyme was assayed using two 273 
substrates: β-naphthyl acetate and α-naphthyl acetate. The chromogenic substrate 274 
solution for β-naphthyl acetate was adapted from Bahar et al. (2012), using fast blue 275 
salt as coupling agent dissolved in dimethyl sulfoxide (DMSO) and diluted in 50 mM 276 
sodium acetate buffer, pH 7.4. The substrate for α-naphthyl acetate was adapted 277 
from Duysen et al. (2011) and Otto et al. (1981) using fast red TR (BDH chemicals 278 
Ltd., Poole, England), as coupling agent, dissolved in DMSO and diluted in 50 mM 279 
sodium acetate buffer, pH 7.4. 280 
 281 
Inhibition of enzymatic activities 282 
 The inhibition of the purified chymotrypsin-like enzyme from the sera of mice 283 
and rats was carried out using phenylmethanesulphonyl fluoride (PMSF) (Darani and 284 
Doenhoff, 2008). The inhibition of the carboxylesterase activity of the purified 285 
enzyme from the sera of mouse and rat using bis-p-nitrophenyl phosphate (BNPP) 286 
was adapted from Xie et al. (2002). Briefly, the purified mouse and rat enzymes were 287 
electrophoresed in replicate 1-D SDS-PAGE gels. After electrophoresis, the gels 288 
were first incubated at room temperature in 2.5% triton X-100 solution for an hour (to 289 
allow the enzymes to refold), rinsed thrice in deionised water, followed by a second 290 
incubation in 0.1 M PBS solution, pH 7.4 for 10 minutes. Thereafter, the gels were 291 
divided into three groups with each of the groups containing three replicates of each 292 
of the purified mouse and rat enzymes. The first group was treated for two hours by 293 
incubation in 10 mM PMSF dissolved in DMSO and diluted in PBS at 370C. A 294 
second was incubated at 370C in a solution containing 5 mM BNPP dissolved in PBS 295 
for 2 hours, while the third group was incubated only in 1xPBS under the same 296 
conditions. The reactions were stopped by washing five times in PBS and the gels 297 
immersed in chromogenic substrate mixtures for detection of enzymatic activity. A 298 
gel piece was taken from each of the three groups and incubated in three substrate 299 
solutions containing the NAPBNE (for the detection of chymotrypsin-like enzyme 300 
activity), β-naphthyl acetate and α-naphthyl acetate (both esterase substrates).       301 
 302 
 303 
 304 
 305 
 306 
 307 
 308 
 309 
 310 
 311 
RESULTS 312 
Investigating the three fractions arising from the fractionation of NMS for the 313 
presence of albumin and the chymotrypsin-like enzyme 314 
 Each of the three fractions from albumin-depleted mouse serum (precipitates 315 
A and B and the supernatant) was investigated using rabbit anti-MSA and anti-NMS 316 
in radial immunodiffusion (RID) for the presence and concentration of albumin and 317 
the chymotrypsin-like enzyme (Fig.1).  318 
 The presence of the chymotrypsin-like enzyme was indicated by a purplish 319 
colour after chromogenic staining using NAPBNE + FBB (Fig. 1b). The results 320 
indicated that precipitate ‘A’ (well 2) had relatively less albumin (Fig. 1a), while 321 
retaining more of the enzyme activity than the other fractions and it was therefore 322 
used for further purification of the enzyme by means of 1-D SDS-PAGE. 323 
   Approximate place for Figure 1 324 
 325 
Purification of the chymotrypsin-like enzyme from precipitate A using SDS-PAGE        326 
Further purification of the enzyme from precipitate A was followed by its isolation 327 
from three successive SDS-PAGE gels, the band with enzymatic activity being 328 
excised from replicate thin strips of the polyacrylamide gel, eluting the enzyme 329 
therefrom and re-electrophoresing the product in a further PAGE. The procedure of 330 
(i) SDS-PAGE, (ii) elution of enzyme activity from gel strips, (iii) re-electrophoresing 331 
in PAGE was repeated two times (Fig. 2). The Coomassie-stained band in lane 5 332 
showing the purified enzyme (blue arrow) was subjected to tandem mass 333 
spectrometry (MS) and the results are shown in Table 1. Tandem MS analysis and a 334 
Mascot search of the Swiss-Prot database revealed significant peptide matches with 335 
mouse (Mus musculus) enzyme carboxylesterase 1C (EST1C_MOUSE) and mouse 336 
alpha-1B-glycoprotein (A1BG_MOUSE). The same proteins with identical amino acid 337 
sequences are present also in the NCBI database (Mouse CES 1C: GI: 247269929 338 
and NP: 031980.2; Mouse A1BG: GI: 124486702 and NP: 001074536.1. 339 
    Approximate place for Figure 2 340 
Approximate place for Table 1 341 
 342 
Purification of the chymotrypsin-like enzyme from rat serum 343 
 A seemingly analogous chymotrypsin-like enzyme was also found after SDS-344 
PAGE and zymography of normal rat serum (NRS) using the same chromogenic 345 
substrate NAPBNE and its coupling agent fast blue B (Darani and Doenhoff, 2008). 346 
The purification of the enzyme in NRS was undertaken to help confirm the identity of 347 
the mouse-derived enzyme and help in the characterization of the enzyme. Extracts 348 
of NRS and NMS sera were loaded into adjacent wells and electrophoresed in 1-D 349 
SDS-PAGE.  The result of zymography to detect enzymatic activity in NMS and NRS 350 
in SDS-PAGE is shown in Fig. 3. The result revealed that the enzyme in NRS has a 351 
slightly smaller size in SDS-PAGE compared to that in NMS. 352 
       Approximate place for Figure 3  353 
                                    354 
 The same method that had been adopted for the purification of the enzyme in 355 
NMS was applied to NRS; i.e., albumin depletion followed by SDS-PAGE, elution 356 
from the gel and re-electrophoresing the contents of the eluate. The result is shown 357 
in Fig. 4.   358 
    Approximate place for Figure 4 359 
 The partially purified Coomassie blue-stained band indicated by the arrow in 360 
Fig. 4b was subjected to tandem mass spectrometry and derived peptides were 361 
searched in MASCOT for protein identification. Significant matches for the peptides 362 
identified by MS were given by two protein entries in the SwissProt database, 363 
namely rat carboxylesterase 1C (RCES 1C) (Table 2) and rat alpha 1B-glycoprotein 364 
(RA1BG) (result not shown). The same proteins with identical peptide sequences are 365 
present in the NCBI database (RCES 1C: GI: 2506388 and NP: 10959.3; RA1BG: 366 
GI: 25453392 and NP: 071594.2).  367 
 The MS result for RCES 1C indicated it was marginally smaller than MCES 368 
1C, as had been indicated by the results of zymography after PAGE (Fig. 3). 369 
  370 
     Approximate place for Table 2 371 
 372 
Investigation of the purified chymotrypsin-like enzyme for esterase activity 373 
 Following the indications from MS that the purified host-derived chymotrypsin-374 
like enzyme from mouse and rat plasmas may be carboxylesterases, samples of the 375 
enzymes purified from mouse and rat sera were subjected to zymography with two 376 
esterase substrates: β-naphthyl acetate and α-naphthyl acetate and NAPBNE as a 377 
positive control. The purified enzymes from both mouse and rat were observed to 378 
hydrolyse both esterase substrates at the same position in the gel as the activity 379 
against NAPBNE, providing additional evidence for the enzyme in question to be an 380 
esterase (Fig. 5).   381 
    Approximate place for Figure 5  382 
 383 
Inhibition of the chymotrypsin-like enzyme and esterase activities in samples purified 384 
from NMS and NRS 385 
 The enzyme activities purified respectively from mouse and rat sera and 386 
visualized by zymography with the two esterase substrates were further 387 
characterized using a carboxylesterase substrate inhibitor: BNPP and the protease 388 
inhibitor PMSF. Both inhibitors were observed to have inhibited the ability of both the 389 
purified enzymes to hydrolyse the two esterase substrates as well as the substrate of 390 
chymotrypsin-like enzymes (Fig. 6b, c, e, f, h, i), as compared to the control groups 391 
which were incubated in the absence of any of the two inhibitors (Fig. 6a, d and g).  392 
    Approximate place for Figure 6 393 
 394 
Enzyme detection in adult worm membrane and purified CES from NMS 395 
The purified CES was investigated in Ouchterlony double immunodiffusion to 396 
ascertain its immunological identity with an enzyme in a detergent extract of mouse-397 
derived adult worms and the enzyme in NMS. A rabbit anti-NMS antiserum was 398 
loaded in one well while the purified CES and unfractionated WM or NMS were 399 
loaded in wells adjacent to each other and opposite the well containing the 400 
antiserum. A pattern of identity of precipitin lines formed between the purified CES 401 
enzyme and an antigen in WM and NMS indicated that antibodies in the anti-NMS 402 
were immunoprecipitating the same molecule in all 3 antigen solutions (Fig. 7). 403 
                                       Approximate place for Figure 7 404 
 405 
Immunofluorescent detection of the host-derived enzyme on adult worms 406 
The presence of the enzyme on the surface of mouse-derived adult worms 407 
was investigated. An immunofluorescent test was done by probing the surface of 408 
freshly perfused adult worms with rabbit antibodies raised against the chymotrypsin-409 
like enzyme derived from a detergent extract of adult worms (WM), while control 410 
worms were probed with rabbit antibodies raised against complete Freund’s adjuvant 411 
(anti-CFA). Results showed that the surfaces of worms probed with antibodies raised 412 
against the chymotrypsin-like enzyme present in a detergent extract of adult worms 413 
were immunofluorescent while control worms were not (Fig. 8). 414 
                                 Approximate place for Figure 8 415 
 416 
Investigating peptide homology between mouse and rat CES 1C 417 
 The homology of the host-derived mouse CES 1C (GI: 247269929, NP: 418 
031980.2) to other mammalian proteins was investigated by a pBlast search of its 419 
amino acid sequence on the NCBI database. The search identified rat CES 1C (GI: 420 
2506388, NP: 10959.3) with a score of 913, an E value of 00 and identity of 83%, as 421 
the mammalian protein most closely similar to that of mouse CES 1C.  422 
 Furthermore, the amino acid sequences of mouse and rat enzymes were 423 
investigated for homology with any human protein. The result revealed that both 424 
enzymes were homologous with human carboxylesterases, one of the most similar 425 
being human CES 1 (monocyte / macrophage serine esterase 1) (GI: 15214585, NP: 426 
AAH12418.1) with peptide identity of 65.52%, a score of 759, and an E value of 00 427 
(result not shown). An alignment of the amino acid sequences of the mouse, rat and 428 
human CES using the ClustalW software revealed a peptide identity of 83.06% 429 
between mouse and rat CES 1C, 65.52% identity between mouse CES 1C and 430 
human CES 1 and 71.22% identity between rat CES 1C and human CES 1. MS-431 
derived peptides which matched each of the mouse and rat sequences are 432 
highlighted by underlining in Fig. 9. 433 
     434 
Approximate place for Figure 9 435 
 436 
 437 
 438 
 439 
 440 
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 442 
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 445 
 446 
 447 
DISCUSSION 448 
 The uptake of host molecules by schistosomes is considered to play a crucial 449 
role in immune evasion and enhancement of parasite survival (Dinguirard and 450 
Yoshino, 2006, McLaren et al., 1975, Skelly, 2004, Smithers et al., 1969). Here, the 451 
purification and characterization of an enzyme, apparently with chymotrypsin-like 452 
activity, and present in a deoxycholic acid (DOC) detergent extract of S. mansoni 453 
adult worms (WM) recovered from infected mice, was undertaken to determine its 454 
identity and perhaps thus provide insight into its role(s) in the parasite-host 455 
relationship.  456 
 The enzyme in DOC extracts of the parasite (WM) was observed to be similar 457 
antigenically and enzymatically to that in normal mouse serum (NMS) and little or 458 
none was present in aqueous extracts of adult worms without DOC (Darani and 459 
Doenhoff, 2008). It has here been confirmed (Fig. 7) that the enzyme in mouse blood 460 
was identical to that in the detergent extracts of worms and purification from NMS 461 
was necessitated because of the limited availability of worm-derived material. The 462 
enzyme was previously reported to have a molecular weight of ~70 KDa (Darani and 463 
Doenhoff, 2008), and thus quite similar to that of serum albumin. The high 464 
concentration of albumin in serum made it difficult to isolate the enzyme and 465 
methods to reduce the concentration of the former were therefore employed (Chen 466 
et al., 2005, Colantonio et al., 2005). 467 
 The method of albumin depletion resulted in fractionating NMS into two 468 
precipitates (first and second) after two successive centrifugations and a supernatant 469 
containing mainly albumin (Fig. 1). The first precipitate, which had a reduced 470 
concentration of albumin but had contained more of the enzyme, was purified further 471 
(Fig. 2). Tandem MS-derived peptides showed a significant match for mouse 472 
carboxylesterase 1C (CES 1C) (Table 1), although some MS-derived peptides also 473 
matched that of mouse α-1B-glycoprotein (result not shown). The host-derived 474 
enzyme was considered most likely to be carboxylesterase as the MS-derived 475 
peptides gave a lower match with α-1B-glycoprotein and the latter is not known to 476 
exhibit any enzymatic activity. The low molecular weight recorded for the enzyme in 477 
MS compared to results from SDS-PAGE could be due to post-translational 478 
modification as these enzymes have been reported to be glycosylated (Bernhard et 479 
al., 2007, Ghesquiere et al., 2006, Otto et al., 1981). 480 
Further evidence of the identity of the chymotrypsin-like enzyme was obtained 481 
from examination of a seemingly analogous enzyme in normal rat serum which in 482 
SDS-PAGE and zymography had a stronger staining intensity and a slightly lower 483 
molecular weight than the enzyme in mouse serum (Fig. 3). Tandem MS analysis of 484 
the partially purified enzyme from rat serum revealed peptides, the sequence of 485 
which significantly matched those of rat CES 1C and rat α-1B-glycoprotein (Table 2). 486 
Interestingly, the MS-derived peptides matching the aligned amino acid sequences 487 
of the mouse and rat enzyme were present in only one or the other sequence, with 488 
the exception of two (Fig. 9).  A study of the properties and characteristics of the two 489 
MS-identified molecules showed similar characteristics / properties between mouse 490 
CES 1C and the chymotrypsin-like enzyme. Thus CES’s, similarly to the serine 491 
protease chymotrypsin, possess a serine residue in their catalytic triad (Fig. 9) 492 
(Satoh and Hosokawa, 2006, Stoops et al., 1969).  493 
The chromogenic substrate for chymotrypsin-like enzymes (N,N,N acetyl-DL-494 
phenylalanine β naphthyl ester: NAPBNE) has previously been reported to be 495 
hydrolysed by rat plasma CES (Choudhury, 1974). The ability of the purified 496 
enzymes from both mouse and rat plasma to hydrolyse two esterase substrates (α-497 
naphthyl acetate and β-naphthyl acetate) (Bahar et al., 2012), is an indication of their 498 
esterolytic capability. Moreover, the protein bands with esterolytic activity were 499 
observed at the same molecular weight as the band which hydrolysed the 500 
chymotrypsin-like substrate (NAPBNE + FBB), a result consistent with the same 501 
molecule being active on the three different substrates. 502 
In terms of mode of action of the chymotrypsin-like enzyme and CES, both 503 
share very similar active sites in possessing a catalytic triad composed of serine, 504 
histidine and either glutamic or aspartic acid (indicated in bold and italicized font in 505 
Fig. 9) (Bahar et al., 2012, Brayer et al., 1979, Satoh and Hosokawa, 2006, Stoops 506 
et al., 1969). Moreover, the observation that the esterase and chymotrypsin-like 507 
activities were both inhibited by PMSF, a chymotrypsin (serine protease) inhibitor 508 
and BNPP, a CES inhibitor, indicated similarities of hydrolytic action of the enzymes 509 
(Fig. 6). Previous findings on the inhibition of the chymotrypsin-like enzyme and CES 510 
in NMS using  PMSF and BNPP respectively, further buttress this point (Darani and 511 
Doenhoff, 2008, Xie et al., 2002). 512 
The immunoprecipitation of the host-derived enzyme in detergent extracts of 513 
the parasite (WM), purified CES and NMS by Ouchterlony double immunodiffusion 514 
using a rabbit anti-NMS revealed patterns of immunological identity in both extracts 515 
(Fig. 7). This indicates that the purified CES is identical to an enzyme in WM. 516 
Moreover, the ability of the immunoprecipitates to hydrolyse substrates of both 517 
chymotrypsin-like enzymes (NAPBNE + FBB) and esterases (α-naphthyl acetate) 518 
helps substantiate the characterization of the enzyme on worms being host-derived 519 
and a CES.  Furthermore, immunofluorescence detection on mouse-derived adult 520 
worms probed with antibodies specific for the chymotrypsin-like enzyme indicated 521 
the host-derived antigen was present on the surface of the worms (Fig. 8). The high 522 
intensity of immunofluorescence observed on adult worms particularly on the female 523 
could be an indication of the possible roles of the enzyme for easing the passage of 524 
the parasite in host’s blood vessels, metabolism and in immune evasion.   525 
 Darani and Doenhoff (2008) reported the chymotrypsin-like enzyme to be 526 
present with high staining intensity in both mouse and rat plasma, but absent among 527 
an array of other mammalian plasmas (hamster; guinea pig, rabbit, bovine or human) 528 
that were assayed. The same has been reported for the CES enzyme in the plasmas 529 
of mouse and rat among the mammalian plasmas investigated (Bahar et al., 2012, 530 
Cerasoli et al., 2000, Li et al., 2005). The reason for CES being present in mouse 531 
and rat blood has been explained in terms of their amino acid sequences. Thus, 532 
mouse and rat blood contain the secreted form of the CES enzyme. Secretion of 533 
CESs from cells in which they are synthesized is normally prevented by the 534 
presence of a retention signal tetra-peptide (namely: histidine, X, glutamic acid and a 535 
terminal leucine, with X representing any amino acid) at the carboxyl-terminal of the 536 
enzyme (Cerasoli et al., 2000). In mice and rats, a disruption in the retention tetra-537 
peptide sequence due to the replacement of the terminal leucine by either threonine 538 
or lysine results in the secretion of the CES from the liver into the blood of these 539 
animals (Hosokawa, 2008, Satoh and Hosokawa, 2006). Twenty families of 540 
carboxylesterase are encoded for in the mouse genome and only one encoded by 541 
the ES-1 gene exhibits the disrupted retention signal, meaning that most CES 542 
activity in mouse serum is generated in the liver by expression of the ES-1 gene 543 
(Duysen et al., 2011).  544 
A BLAST analysis of sequences in the NCBI database indicated the most 545 
similar homologue of mouse CES 1C was rat CES 1C and that human brain CES 546 
was the closest human CES to mouse CES 1C (results not shown). However, a 547 
human serine carboxylesterase expressed at high levels in the liver and less in lungs 548 
and heart was of particular interest as it has been shown to possess convertase 549 
activity in human alveolar lavages and to function as a lung detoxification enzyme 550 
(Munger et al., 1991). Similarly to mouse CES 1C, inhibition of the human serine 551 
carboxylesterase by PMSF and BNPP has also been reported (Munger et al., 1991). 552 
An alignment of amino acid sequences of the mouse, rat and human CES using 553 
ClustalW software revealed an identity of 83.06% between mouse and rat CES 1C, 554 
65.52% identity between mouse CES 1C and human CES and 71.22% identity 555 
between the rat and human molecules, reflecting homology between all three 556 
enzymes (Fig. 9).  557 
A requirement for detergent (DOC) to extract the enzyme into solution 558 
suggests it is membrane-bound in the parasite, perhaps on the outer surface. If that 559 
is so, several roles could be suggested to explain the presence of CES on the 560 
surface membrane. Firstly, mouse CES 1C could be exploited by S. mansoni as an 561 
immunological disguise for masking surface antigens, thereby preventing the 562 
recognition and activation by antigen-presenting cells and activation of the 563 
complement system (Furlong et al., 1992).  564 
Alternatively or additionally, the convertase potential of CES 1C (Krishnasamy 565 
et al., 1998), could be exploited by S. mansoni  for inactivating the complement 566 
system of the host for the purpose of immune evasion. Another possible role of the 567 
CES on the surface of S. mansoni could be to neutralize harmful / foreign host 568 
molecules which pose a threat to the parasite’s survival, specifically those stemming 569 
from anti-parasite immune activity. Members of the CES family from the liver 570 
microsome in the endoplasmic reticulum are known to hydrolyse and inactivate 571 
foreign substances such as toxins, although their physiological role in vivo is as yet 572 
unclear (Krishnasamy et al., 1998).  573 
Mouse CES 1C has been shown to be capable of exhibiting convertase 574 
activity of lung surfactant subtypes (Genetta et al., 1988, Krishnasamy et al., 1998). 575 
S. mansoni could thus perhaps ‘use’ the CES 1C obtained from its mouse host’s 576 
blood to ease its passage through the host blood vessels as it may help maintain 577 
blood vessel stability by inhibiting blood vessel constriction. Mouse blood CES is 578 
known to metabolise several pharmaceutical compounds such as temocapril: an 579 
angiotensin converting enzyme inhibitor (Bahar et al., 2012, Takai et al., 1997). 580 
Angiotensin converting enzyme plays an important physiological role, the outcome of 581 
which is a constriction of blood vessels, thereby raising blood pressure. Consistent 582 
with this pharmacological role, the enzyme has previously been found by indirect 583 
immunofluorescence to be present on the surface of mouse lung-derived 584 
schistosomula, but not on the surface of mechanically transformed larvae (Darani 585 
and Doenhoff, 2008). 586 
Mammalian CES’s are known to be involved in lipid metabolism (Holmes et 587 
al., 2010, Meyer et al., 1970, Smith et al., 1970). The metabolic potential of CES 588 
could be manipulated by S. mansoni in hydrolysing acquired host lipids and 589 
lipoproteins, as the parasite cannot synthesize all its needed fatty acids and steroids 590 
ab initio (Berriman et al., 2009, Brouwers et al., 1997). These are important in the 591 
parasite’s survival as they serve a crucial role in nutrition, membrane synthesis and 592 
maintenance (Dinguirard and Yoshino, 2006, Furlong, 1991, Furlong et al., 1992). 593 
The high intensity of immunofluorescence observed herein on mouse-derived adult 594 
worms particularly on the female could be directly proportional to the above 595 
metabolic roles which are crucial for their survival.   596 
Paradoxically, none of the above possible roles of blood-borne CES enable S. 597 
mansoni to survive well in the rat, a host considered relatively non-permissive for this 598 
schistosome species (Cioli et al., 1977), nor apparently is a presence of such an 599 
enzyme in the blood of humans a necessity for the S. mansoni-permissiveness of 600 
that host species. However, the successful characterization of a carboxylesterase 601 
seemingly present in extracts of S. mansoni is an addition to the list of host-derived 602 
molecules acquired by this schistosome species and is the first enzyme to be 603 
recorded to have this role. The means by which the molecule adheres to the 604 
schistosome remains to be determined. Moreover, the existence of a similar serine 605 
carboxylesterase in humans, released by alveolar macrophages, is noteworthy, but  606 
investigations to ascertain if it is exploited by the parasite in any of the ways 607 
suggested here for mouse CES 1C would of course be difficult.  608 
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Table 1: MASCOT search output of tandem MS data from the purified ~85 kDa gel 829 
band  from mouse serum. 830 
 831 
 832 
 833 
 834 
 835 
 836 
 837 
 838 
 839 
 840 
 841 
 842 
 843 
 844 
 845 
 846 
Peptides with significant scores are shown in italics. Mascot Protein score: The sum 847 
of all the peptide ion scores matching a protein; Mass: predicted protein mass in 848 
Daltons (Da); Coverage: Percentage of sequence covered by MS-matched peptides; 849 
Peptide Ion score: A score assigned to individual matching peptide by Mascot based 850 
on the probability of best match; Expect: Frequency of chance of obtaining an equal 851 
or higher score for a peptide. 852 
 853 
Carboxylesterase 1C (Mus musculus) SwissProt, 
Mascot Protein Score: 313, Mass: 61017, Coverage: 
15%, pI: 4.97 
Peptide match Peptide Ion 
Score     
Expect 
MNEETASLLLR 75 0.0001 
EGASEEETNLSK 70 0.00032 
APEEILAEK 52 0.019 
QKTESELLEISGK 51 0.023 
FAPPQPAEPWSFVK 22 18 
FWANFAR 22 17 
TESELLEISGK 18 56 
ISEDCLYLNIYSPADLTK 9 2.8e+02 
Table 2: MASCOT search output of tandem MS data from the purified ~85 kDa gel 854 
band  from rat serum. Other details as in the legend to Table 1.  855 
 856 
 857 
 858 
 859 
 860 
 861 
 862 
 863 
 864 
 865 
Legends are the same as in table 1 866 
 867 
 868 
 869 
 870 
 871 
 872 
Carboxylesterase 1C (Rattus norvegicus) 
SwissProt, Mascot Protein Score: 182, 
Mass: 60136, pI: 5.51, Coverage: 12% 
Peptide match Score     Expect 
EGASEEETNLSK 69 0.00034 
TPEEILTEK 50 0.039 
LLADMLSTGK 40 0.31 
NPPQTEHTEHT 9 4.1e+02 
SFNTVPYIVGFNK 8 4.5e+02 
FAPPEPAEPWSFVK 6 7.2e+02 
Figure legends 873 
 874 
Fig. 1. Radial immunodiffusion of diluted NMS and fractions from albumin-875 
depleted NMS. Immunoprecipitation was carried out with: (a) rabbit anti-whole 876 
mouse serum albumin antiserum (anti-MSA) and (b) anti-NMS and stained with 877 
chromogenic substrate NAPBNE+FBB. Wells (1) NMS, (2) Precipitate A of albumin-878 
depleted NMS, (3) Precipitate B of albumin-depleted NMS, (4) supernatant from 879 
albumin-depleted NMS. (2 μg of each eluate was loaded into each of the wells). 880 
 881 
 882 
 883 
 884 
 885 
 886 
 887 
 888 
 889 
 890 
 891 
 892 
 893 
            894 
 895 
Fig. 2. Steps towards the purification of the chymotrypsin-like enzyme in 896 
normal mouse serum (NMS) using an albumin-depletion method and repeated 897 
SDS-PAGEs. (M) Molecular weight markers, (1) NMS, (2 & 3) Precipitate A from 898 
albumin-depleted NMS. (4 & 5) Purified enzyme after two successive SDS-PAGEs. 899 
Lanes 1, 3 & 5 were stained with Coomassie blue. Lanes 2 & 4 reveal the presence 900 
of the enzyme by zymography. Blue arrow shows the gel position of the enzyme. 901 
 902 
 903 
 904 
 905 
 906 
 907 
 908 
                                            909 
Fig. 3. Zymography of SDS-PAGE of NRS and NMS to display the enzyme using 910 
the chromogenic substrate mixture of NAPBNE + FBB. M: Molecular weight 911 
marker (1) NRS, (2) NMS (2 μg was loaded in each well). 912 
 913 
 914 
                        915 
Fig. 4. Purified chymotrypsin-like enzyme in rat serum. (M) Molecular weight 916 
marker, (a) zymography of purified rat enzyme, (b) Purified rat enzyme stained in 917 
Safe-blue Coomassie stain and investigated in MS. 918 
         919 
Fig. 5. SDS-PAGE and zymography investigating the purified enzyme from 920 
mouse and rat using two esterase substrates. (a)  Stained with chymotrypsin-like 921 
enzyme substrate: NAPBNE + FBB, (b) stained with carboxylesterase enzyme 922 
substrate: β- naphthyl acetate + FBB, (c) stained with carboxylesterase enzyme 923 
substrate: α- naphthyl acetate + fast red TR. (M) Molecular weight markers, (1) 924 
purified enzyme from NMS, (2) purified enzyme from NRS. 925 
 926 
 927 
 928 
 929 
 930 
 931 
 932 
 933 
 934 
 935 
 936 
 937 
 938 
                             939 
Fig. 6. Investigating the effect of CES inhibitor bis-p-nitrophenyl phosphate 940 
(BNPP) and the protease inhibitor phenylmethylsulphonyl fluoride (PMSF) on 941 
purified CES. (a, b & c) was assayed with chymotrypsin-like substrate: NAPBNE + 942 
FBB. (d, e & f) was assayed with CES substrate: β-naphthyl acetate + fast blue salt. 943 
(g, h & i) was assayed with CES substrate: α-naphthyl acetate + fast red TR. (a, d & 944 
g) were controls (b, e & h) were treated with 5 mM BNPP inhibitor. (c, f & i) were 945 
treated with 10 mM PMSF inhibitor. (M) Molecular weight marker, (1) Purified 946 
enzyme from mouse, (2) Purified enzyme from rat. 947 
 948 
 949 
 950 
 951 
                                               952 
Fig. 7. Ouchterlony (Immunodiffusion) and zymography showing that the 953 
purified CES from NMS and an antigen in WM are immunoprecipitated similarly 954 
by antibodies in a rabbit anti-NMS. Gels ‘a’ and ‘b’ (1) rabbit anti-NMS, (2) NMS, 955 
(3) WM. Gels ‘c’ and ‘d’ (1) rabbit anti-NMS, (2) purified CES, (3) WM. Gels  ‘a’ and 956 
‘c’ were stained with the chromogenic substrates for chymotrypsin-like enzyme 957 
(NAPBNE and FBB), ‘b’ and ‘d’ were stained with an esterase substrate (α-napththyl 958 
acetate and fast red TR). All stained gels were photographed over direct light. 959 
                          960 
 Fig. 8. Immunofluorescence probing the surface of mouse-derived S. mansoni 961 
adult worms. (a) Worm was probed with a rabbit antiserum raised against adult 962 
worm-derived mouse chymotrypsin-like enzyme; (b) was probed with a rabbit anti-963 
complete Freund’s adjuvant antiserum (anti-CFA). 964 
CLUSTAL 2.1 Multiple Sequence Alignments 965 
Sequence type explicitly set to Protein 966 
Sequence format is Pearson 967 
Sequence 1: MCES1C       554 aa 968 
Sequence 2: RCES1C       549 aa 969 
Sequence 3: HCES1        566 aa 970 
Sequences (1:2) Aligned. Score: 83.0601 971 
Sequences (1:3) Aligned. Score: 65.5235 972 
Sequences (2:3) Aligned. Score: 71.2204 973 
Guide tree file created:   [clustalw.dnd] 974 
 975 
Group 1: Sequences:   2      Score: 8261 976 
Group 2: Sequences:   3      Score: 8323 977 
Alignment Score 7820 978 
 979 
CLUSTAL-Alignment file created [clustalw.aln] 980 
 981 
MCES1C     MWLHALVWASLAVCPILGHSLLPPVVDTTQGKVLGKYISLEGFEQPVAVFLGVPFAKPPL 982 
RCES1C     MWLCVLVWASLAACPIWGHPSSPPVVDTTKGKVLGKYVSLEGFTQPVAVFLGVPFAKPPL 983 
HCES1      MWLPALVLATLAASAAWGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIFLGIPFAKPPL 984 
           *** .** *:**...  **.  ******.:******::***** ****:***:******* 985 
 986 
MCES1C     GSLRFAPPQPAEPWSFVKNATSYPPMCSQDAGWAKILSDMFSTEKEILPLKISEDCLYLN 987 
RCES1C     GSLRFAPPEPAEPWSFVKNTTTYPPMCSQDGVVGKLLADMLSTGKENIPLEFSEDCLYLN 988 
HCES1      GPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSELFTNRKENIPLKLSEDCLYLN 989 
           *.***:**:**********:*:*****:**   .::*:::::. ** :**::******** 990 
 991 
MCES1C     IYSPADLTKSSQLPVMVWIHGGGLVIGGASPYNGLALSAHENVVVVTIQYRLGIWGLFST 992 
RCES1C     IYSPADLTKNSRLPVMVWIHGGGLIIGGASPYSGLALSAHENVVVVTIQYRLGIWGLFST 993 
HCES1      IYTPADLTKKNRLPVMVWIHGGGLMVGAASTYDGLALAAHENVVVVTIQYRLGIWGFFST 994 
           **:******..:************::*.**.*.****:******************:*** 995 
 996 
MCES1C     GDEHSPGNWAHLDQLAALRWVQDNIANFGGNPDSVTIFGESSGGISVSVLVLSPLGKDLF 997 
RCES1C     GDEHSRGNWAHLDQLAALRWVQDNIANFGGNPDSVTIFGESAGGVSVSVLVLSPLAKNLF 998 
HCES1      GDEHSRGNWGHLDQVAALRWVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLF 999 
           ***** ***.****:***********.*****.********:** **********.*:** 1000 
 1001 
MCES1C     HRAISESGVVINTNVGKK-NIQAVNEIIATLSQCNDTSSAAMVQCLRQKTESELLEISGK 1002 
RCES1C     HRAISESGVVLTTNLDKK-NTQAVAQMIATLSGCNNTSSAAMVQCLRQKTEAELLELTVK 1003 
HCES1      HRAISESGVALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTLK 1004 
           *********.:.: : ** : :.: : **  : *: *:**.**:******* **** : * 1005 
 1006 
MCES1C     LVQYNI-----------SLSTMIDGVVLPKAPEEILAEKSFNTVPYIVGFNKQEFGWIIP 1007 
RCES1C     LDNT-------------SMSTVIDGVVLPKTPEEILTEKSFNTVPYIVGFNKQEFGWIIP 1008 
HCES1      MKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVGINKQEFGWLIP 1009 
           :                 :.*:***::* *:***: :*:.*:****:**:*******:** 1010 
 1011 
MCES1C     MMLQNLLPEGKMNEETASLLLRRFHSELNISESMIPAVIEQYLRGVDDPAKKSELILDMF 1012 
RCES1C     TMMGNLLSEGRMNEKMASSLLRRFSPNLNISESVIPAIIEKYLRGTDDPAKKKELLLDMF 1013 
HCES1      MLMSYPLSEGQLDQKTAMSLLWKSYPLVCIAKELIPEATEKYLGGTDDTVKKKDLFLDLI 1014 
           ::   *.**::::: *  ** :  . : *::.:**   *:** *.**..**.:*:**:: 1015 
 1016 
MCES1C     GDIFFGIPAVLLSRSLRDAGVSTYMYEFRYRPSFVSDKRPQTVEGDHGDEIFFVFGAPLL 1017 
RCES1C     SDVFFGIPAVLMSRSLRDAGAPTYMYEFQYRPSFVSDQRPQTVQGDHGDEIFSVFGTPFL 1018 
HCES1      ADVMFGVPSVIVARNHRDAGAPTYMYEFQYRPSFSSDMKPKTVIGDHGDELFSVFGAPFL 1019 
           .*::**:*:*:::*. ****..******:***** ** :*:** ******:* ***:*:* 1020 
 1021 
MCES1C     KEGASEEETNLSKMVMKFWANFARNGNPNGEGLPHWPEYDEQEGYLQIGATTQQAQRLKA 1022 
RCES1C     KEGASEEETNLSKLVMKFWANFARNGNPNGEGLPHWPEYDQKEGYLQIGATTQQAQKLKG 1023 
HCES1      KEGASEEEIRLSKMVMKFWANFARNGNPNGEGLPHWPEYNQKEGYLQIGANTQAAQKLKD 1024 
           ******** .***:*************************:::********.** **:**  1025 
 1026 
MCES1C     EEVAFWTELLAKNPPETDPTEHTEHK 1027 
RCES1C     EEVAFWTELLAKNPPQTEHTEHT--- 1028 
HCES1      KEVAFWTNLFAKKAVEKPPQTEHIEL 1029 
           :******:*:**:. :.    .     1030 
 1031 
MCES1C:0.11318, 1032 
RCES1C:0.05621, 1033 
HCES1:0.23158); 1034 
 1035 
 1036 
Fig. 9. An alignment of mouse and rat CES 1C and human CES 1037 
MS derived peptides that match the aligned sequences of mouse and rat CES 1C in 1038 
MASCOT are underlined. Residues forming the catalytic triad for CES and 1039 
chymotrypsin-like enzymes are shown in bold font and italicised. 1040 
 1041 
 1042 
